Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Pravastatin sodium
Aspen Pharma Pty Ltd
Medicine Registered
PRAVACHOL- Consumer Medicine Information Page 1 of 3 PRAVACHOL ® _pravastatin sodium _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET The information in this leaflet will answer some of the questions you may have about _PRAVACHOL_. This leaflet does not tell you everything about the medicine. Your doctor and pharmacist have been provided with full information and can answer any questions you may have. This leaflet is no substitute for talking with your doctor or pharmacist. You should follow all advice from your doctor when being treated with this medicine. ASK YOUR DOCTOR OR PHARMACIST IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE. You should read this leaflet carefully before starting _PRAVACHOL_ and keep it in a safe place to refer to later. WHAT IS IT USED FOR _ _ _PRAVACHOL_ is used to treat people who have had a heart attack or an episode of unstable angina, or who have high blood cholesterol levels. In these people _PRAVACHOL_ can reduce the risk of further heart disease, reduce the possibility of needing a bypass operation, or reduce the risk of having a stroke. _ _ It lowers high blood cholesterol levels (Doctors call this hypercholesterolaemia). It is also used if your cholesterol levels are normal if you have had a heart attack or an episode of unstable angina. It is used to treat heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years and older as an adjunct to diet and lifestyle changes. If you have had a heart attack, an episode of unstable angina or you have too much cholesterol in your blood, then you have an increased risk of a blood clot forming in your blood vessels and causing a blockage. Blood vessels that become Read the complete document
PRAVACHOL- Product Information Page 1 of 22 PRAVACHOL PRODUCT INFORMATION NAME OF THE MEDICINE PRAVACHOL PRAVACHOL (Pravastatin Sodium) (JAN, USAN, INN). DESCRIPTION PRAVACHOL is one of a new class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, that reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3- hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme catalysing the early rate-limiting step in cholesterol biosynthesis, conversion of HMG-CoA to mevalonate. The CAS number for pravastatin sodium is 81131-70-6. PRAVACHOL (Pravastatin Sodium) is designated chemically as : (3R,5R)-7-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6-hydroxy-2-methyl-8-[(S)-2- methylbutyryloxy-1-naphthyl]]-3,5-dihydroxyheptanoic acid, sodium salt, and has the following structure: PRAVASTATIN sodium is an odourless, white to off-white, fine or crystalline powder. It is a relatively polar hydrophilic compound with a partition coefficient (octanol/water) of 0.59 at a pH of 7.0. It is soluble in methanol and water (>300 mg/mL), slightly soluble in isopropanol, and practically insoluble in acetone, acetonitrile, chloroform, and ether. PRAVACHOL tablets contain the following inactive ingredients: lactose, povidone, microcrystalline cellulose, croscarmellose sodium and magnesium stearate, magnesium oxide and iron oxide – yellow. PRAVACHOL- Product Information Page 2 of 22 CLINICAL PHARMACOLOGY PRAVACHOL produces its lipid-lowering effect in two ways. First, as a consequence of its reversible inhibition of HMG-CoA reductase activity, it affects modest reductions in intracellular pools of cholesterol. This results in an increase in the number of LDL-receptors on cell surfa Read the complete document